Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma

被引:98
作者
Enarsson, Karin
Lundgren, Anna
Kindlund, Bert
Hermansson, Mikael
Roncador, Giovanna
Banham, Alison H.
Lundin, B. Samuel
Quiding-Jarbrink, Marianne
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Inst Biomed, S-40530 Gothenburg, Sweden
[2] Univ Gothenburg, GUVAX, Vaccine Res Inst, S-40530 Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Surg, S-41345 Gothenburg, Sweden
[4] CNIO, Biotechnol Program, Monoclonal Antibodies Unit, Madrid, Spain
[5] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England
关键词
Helicobacter pylori; regulatory T cells; human; mucosal immunity; migration;
D O I
10.1016/j.clim.2006.07.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(high) FOXP3-expressing regulatory T cells (Treg) can suppress immune responses to infections and tumors, thereby promoting microbial persistence and tumor progression. However, little is known about the phenotype and function of human mucosal Treg. Therefore, we analyzed the suppressive activity and homing phenotype of Treg in gastric mucosa of Helicobacter pylori-infected gastric adenocarcinoma patients. We found increased numbers of CD4(+)FOXP3(+) Treg in the tumor compared to tumor-free gastric mucosa. Gastric Treg cells were able to suppress H. pylori-induced T cell proliferation and IFN-gamma production. Furthermore, gastric Treg expressed increased levels of L-selectin and CCR4, compared to non-Treg cells, suggesting that these receptors contribute to Treg recruitment. The presence of functional antigen-specific Treg in H. pylori-infected gastric mucosa supports an important rote for these cells in suppression of mucosal effector T cell responses, which probably contribute to bacterial persistence and possibly also to gastric tumor progression. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:358 / 368
页数:11
相关论文
共 52 条
  • [1] CELL-CELL INTERACTIONS IN CONJUGATING ESCHERICHIA-COLI - CON-MUTANTS AND STABILIZATION OF MATING AGGREGATES
    ACHTMAN, M
    SCHWUCHOW, S
    HELMUTH, R
    MORELLI, G
    MANNING, PA
    [J]. MOLECULAR & GENERAL GENETICS, 1978, 164 (02): : 171 - 183
  • [2] Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells
    Akhiani, AA
    Pappo, J
    Kabok, Z
    Schön, K
    Gao, W
    Franzén, LE
    Lycke, N
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (12) : 6977 - 6984
  • [3] CD4+CD25high regulatory cells in human peripheral blood
    Baecher-Allan, C
    Brown, JA
    Freeman, GJ
    Hafler, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1245 - 1253
  • [4] Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells
    Baratelli, F
    Lin, Y
    Zhu, L
    Yang, SC
    Heuzé-Vourc'h, N
    Zeng, G
    Reckamp, K
    Dohadwala, M
    Sharma, S
    Dubinett, SM
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (03) : 1483 - 1490
  • [5] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    [J]. NATURE, 2002, 420 (6915) : 502 - 507
  • [6] HELICOBACTER-PYLORI AND THE PATHOGENESIS OF GASTRODUODENAL INFLAMMATION
    BLASER, MJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) : 626 - 633
  • [7] CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis
    Boyer, O
    Saadoun, D
    Abriol, J
    Dodille, M
    Piette, JC
    Cacoub, P
    Klatzmann, D
    [J]. BLOOD, 2004, 103 (09) : 3428 - 3430
  • [8] An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection
    Cabrera, R
    Tu, ZK
    Xu, YL
    Firpi, RJ
    Rosen, HR
    Liu, C
    Nelson, DR
    [J]. HEPATOLOGY, 2004, 40 (05) : 1062 - 1071
  • [9] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    Curiel, TJ
    Coukos, G
    Zou, LH
    Alvarez, X
    Cheng, P
    Mottram, P
    Evdemon-Hogan, M
    Conejo-Garcia, JR
    Zhang, L
    Burow, M
    Zhu, Y
    Wei, S
    Kryczek, I
    Daniel, B
    Gordon, A
    Myers, L
    Lackner, A
    Disis, ML
    Knutson, KL
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2004, 10 (09) : 942 - 949
  • [10] Dubinett SM, 2003, PROG EXP TUMOR RES, V37, P138